Väänänen KH - Search Results

1

Novel interaction of Rab13 and Rab8 with endospanins.

Hirvonen MJ, Büki KG, Sun Y, Mulari MT, Härkönen PL, Väänänen KH. Hirvonen MJ, et al. Among authors: vaananen kh. FEBS Open Bio. 2013 Jan 22;3:83-8. doi: 10.1016/j.fob.2013.01.004. Print 2013. FEBS Open Bio. 2013. PMID: 23772379 Free PMC article.

2

Bone effects of glucocorticoid therapy.

Väänänen KH, Härkönen PL. Väänänen KH, et al. Ernst Schering Res Found Workshop. 2002;(40):55-64. doi: 10.1007/978-3-662-04660-9_4. Ernst Schering Res Found Workshop. 2002. PMID: 12355728 Review. No abstract available.

3

Inactivation of estrogen receptor α in bone-forming cells induces bone loss in female mice.

Määttä JA, Büki KG, Gu G, Alanne MH, Vääräniemi J, Liljenbäck H, Poutanen M, Härkönen P, Väänänen K. Määttä JA, et al. FASEB J. 2013 Feb;27(2):478-88. doi: 10.1096/fj.12-213587. Epub 2012 Oct 16. FASEB J. 2013. PMID: 23073829

4

Inactivation of the androgen receptor in bone-forming cells leads to trabecular bone loss in adult female mice.

Määttä JA, Büki KG, Ivaska KK, Nieminen-Pihala V, Elo TD, Kähkönen T, Poutanen M, Härkönen P, Väänänen K. Määttä JA, et al. Bonekey Rep. 2013 Nov 6;2:440. doi: 10.1038/bonekey.2013.174. eCollection 2013. Bonekey Rep. 2013. PMID: 24422138 Free PMC article.

5

Fam3c modulates osteogenic cell differentiation and affects bone volume and cortical bone mineral density.

Määttä JA, Bendre A, Laanti M, Büki KG, Rantakari P, Tervola P, Saarimäki J, Poutanen M, Härkönen P, Väänänen K. Määttä JA, et al. Bonekey Rep. 2016 Apr 6;5:787. doi: 10.1038/bonekey.2016.14. eCollection 2016. Bonekey Rep. 2016. PMID: 27087939 Free PMC article.

6

Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice.

Tuomela JM, Valta MP, Väänänen K, Härkönen PL. Tuomela JM, et al. BMC Cancer. 2008 Mar 28;8:81. doi: 10.1186/1471-2407-8-81. BMC Cancer. 2008. PMID: 18371232 Free PMC article.

7

Effects of the selective estrogen receptor modulator ospemifene on bone in rats.

Kangas L, Härkönen P, Väänänen K, Peng Z. Kangas L, et al. Horm Metab Res. 2014 Jan;46(1):27-35. doi: 10.1055/s-0033-1355356. Epub 2013 Oct 9. Horm Metab Res. 2014. PMID: 24108389

8

Alendronate disturbs vesicular trafficking in osteoclasts.

Alakangas A, Selander K, Mulari M, Halleen J, Lehenkari P, Mönkkönen J, Salo J, Väänänen K. Alakangas A, et al. Calcif Tissue Int. 2002 Jan;70(1):40-7. doi: 10.1007/s002230010047. Epub 2001 Dec 21. Calcif Tissue Int. 2002. PMID: 11907706

9

Effects of ospemifene on breast tissue morphology and proliferation: a comparative study versus other selective estrogen receptor modulators in ovariectomized rats.

Kangas L, Härkönen P, Väänänen K, Keskitalo J, Eigéliené N. Kangas L, et al. Horm Metab Res. 2014 May;46(5):328-32. doi: 10.1055/s-0034-1367032. Epub 2014 Feb 13. Horm Metab Res. 2014. PMID: 24526372

10

Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats.

Qu Q, Zheng H, Dahllund J, Laine A, Cockcroft N, Peng Z, Koskinen M, Hemminki K, Kangas L, Väänänen K, Härkönen P. Qu Q, et al. Endocrinology. 2000 Feb;141(2):809-20. doi: 10.1210/endo.141.2.7342. Endocrinology. 2000. PMID: 10650964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

87 results

Search Page